Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biocon Limited ( (IN:BIOCON) ) has provided an update.
Biocon Limited has closed its Qualified Institutions Placement (QIP) of equity shares, initiated on January 12, 2026, after receiving applications and funds from eligible qualified institutional buyers. The company’s Fund Raising Committee approved the closure of the issue on January 14, 2026, and allocated 112,664,585 equity shares at an issue price of ₹368.35 per share, representing a 5% discount to the floor price of ₹387.74, and finalized allocation confirmations to participating investors, marking a significant capital-raising step that may strengthen its balance sheet and support future growth initiatives.
More about Biocon Limited
Biocon Limited is an Indian biopharmaceutical company headquartered in Bengaluru, operating in the pharmaceuticals and life sciences industry. It focuses on developing and manufacturing biologics, biosimilars, and other pharmaceutical products for domestic and global markets, with its equity shares listed on both BSE and the National Stock Exchange of India.
Average Trading Volume: 147,947
Technical Sentiment Signal: Buy
Current Market Cap: 496.5B INR
See more insights into BIOCON stock on TipRanks’ Stock Analysis page.